Share your thoughts: Consultation on draft National Priority List of Pediatric Drugs
From: Health Canada
Current status: Open
Opened on October 21, 2024, and will close to new input on December 20, 2024.
As part of the Pediatric Drug Action Plan, Health Canada is working with stakeholders to develop a National Priority List of Pediatric Drugs. This priority list will identify drugs that address unmet pediatric health needs in Canada and help to facilitate access to these drugs.
Learn more:
Join in: how to participate
Share your ideas online
Review the draft list and use the online form to give your feedback. We will consider all responses received through this consultation.
Why we are consulting
We held a 60-day online nomination process with members of the pediatric medical and pharmacist community to identify drugs that could be considered for the priority list. An external group of pediatric experts appointed by us considered the feedback when drafting an initial list for further consideration.
We are now consulting with people in Canada on the proposed list. The consultation is open for 60 days.
Pediatric External Reference Group
Who is the focus of this consultation
This consultation is open to all people living in Canada. This includes patients, family members, advocacy organizations and anyone else who may be interested.
Related information
Contact us
Centre for Policy, Pediatrics and International Collaboration
Biologic and Radiopharmaceutical Drugs Directorate
Health Products and Food Branch
Health Canada
Email: brdd-cppic_brdd-cppci@hc-sc.gc.ca
Page details
- Date modified: